SCHEMBL15422342

SCHEMBL15422342

CS(=O)(=O)C(CCc1cc(-c2ccccc2)no1)C(N)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.56
MMP8 P22894 2/20 0.56
MMP12 P39900 2/20 0.56
SMN1; SMN2 Q16637 7/20 0.48
NPC1 O15118 6/20 0.48
RAB9A P51151 6/20 0.48
LMNA P02545 2/20 0.48
NOTUM Q6P988 2/20 0.48
MMP3 P08254 1/20 0.46
MMP10 P09238 1/20 0.46
MMP9 P14780 1/20 0.46
MMP13 P45452 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 1/20 0.43
ERAP2 Q6P179 2/20 0.42
ERAP1 Q9NZ08 2/20 0.42
LNPEP Q9UIQ6 2/20 0.42
PTGS2 P35354 1/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15422784 0.79 NOTUM (0.48) SMN1; SMN2NPC1RAB9ALMNANOTUM
SCHEMBL10157 0.74 MMP12 (0.50) MMP2MMP8MMP12MMP9MMP13
SCHEMBL15422345 0.72 MMP2 (0.44) MMP2MMP8MMP12SMN1; SMN2NPC1
SCHEMBL14122225 0.72 MMP12 (1.00) MMP2MMP8MMP12SMN1; SMN2NPC1
SCHEMBL14122228 0.72 MMP12 (1.00) MMP2MMP8MMP12SMN1; SMN2NPC1
SCHEMBL1586577 0.72 MMP2 (0.67) MMP2MMP8MMP12SMN1; SMN2NPC1
SCHEMBL15422343 0.71 MMP2 (0.51) MMP2MMP8MMP12SMN1; SMN2NPC1
SCHEMBL15453836 0.71 PDE10A (0.40) CYP3A4CYP2D6CYP2C19HTT
SCHEMBL14209989 0.70 MMP12 (0.96) MMP2MMP8MMP12NOTUMMMP3
SCHEMBL23881749 0.70 NOTUM (0.74) MMP2MMP8MMP12SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748466-B2 Isoxazole derivatives useful as antibacterial agents PFIZER INC. (US) 2014-06-10 US disclosed
US-20140024690-A1 Isoxazole Derivatives Useful As Antibacterial Agents PFIZER INC. (US) 2014-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140024690-A1 Isoxazole Derivatives Useful As Antibacterial Agents HAX1, PRXL2A, PRDX1 MMP2 240/4885MMP8 132/4885MMP12 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.